A Clinical Trial of an Alphavirus Replicon Vaccine for Cytomegalovirus (CMV)

NCT00439803 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Cytomegalovirus Infections

Interventions

BIOLOGICAL: AVX601
BIOLOGICAL: Placebo
BIOLOGICAL: AVX601
BIOLOGICAL: Placebo
BIOLOGICAL: AVX601
BIOLOGICAL: AVX601
BIOLOGICAL: AVX601
BIOLOGICAL: Placebo

Sponsor

AlphaVax, Inc.